Adaptive Anti-MICA Antigen Binding Fragments for Extreme Environments

Publication ID: 24-11857571_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Anti-MICA Antigen Binding Fragments for Extreme Environments,” Published Technical Disclosure No. 24-11857571_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857571_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,571.

Summary of the Inventive Concept

This inventive concept adapts anti-MICA antigen binding fragments for specific, narrow markets and unique operational environments, enhancing their effectiveness in extreme weather conditions, high-security settings, and disaster relief scenarios.

Background and Problem Solved

The original patent disclosed anti-MICA antigen binding fragments, but these fragments have limitations in certain environments. This new inventive concept addresses these limitations by providing specialized variations and niche solutions, enabling the effective detection and treatment of MICA-expressing cancer cells in extreme weather conditions, high-security environments, and disaster relief scenarios.

Detailed Description of the Inventive Concept

The inventive concept comprises a system for detecting MICA-expressing cancer cells in extreme weather conditions, featuring a polynucleotide encoding an anti-MICA chimeric antigen receptor (CAR) and a weather-resistant detector unit. Additionally, the concept includes a method for treating MICA-expressing cancer cells in a high-security environment, utilizing an anti-MICA CAR-expressing cell and a secure communication network. Furthermore, a disaster relief kit is proposed, comprising a portable container housing an anti-MICA CAR-expressing cell, a portable detector unit, and a communication device for contacting emergency services.

Novelty and Inventive Step

The new claims introduce novel and non-obvious elements, such as weather-resistant detector units, secure communication networks, and portable disaster relief kits, which significantly enhance the functionality and applicability of the original anti-MICA antigen binding fragments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include adapting the anti-MICA CAR-expressing cells for use in space exploration, developing miniaturized detector units for wearable devices, or integrating the secure communication network with existing emergency response systems.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the fields of cancer treatment, disaster relief, and high-security medical services, with potential applications in extreme weather conditions, such as search and rescue operations, and in high-security environments, such as military medical facilities.

Original Patent Information

Patent NumberUS 11,857,571
TitleAnti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
Assignee(s)The Trustees of Dartmouth College